BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7002567)

  • 1. Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.
    Leonetti G; Terzoli L; Bianchini C; Sala C; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):365-74. PubMed ID: 7002567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of once and twice daily atenolol in hypertension.
    Castleden CM; Dathan JR; George CF
    Postgrad Med J; 1977 Nov; 53(625):679-82. PubMed ID: 339214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
    Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
    Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.
    Fitzgerald JD; Ruffin R; Smedstad KG; Roberts R; McAinsh J
    Eur J Clin Pharmacol; 1978 May; 13(2):81-9. PubMed ID: 658112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
    McGrath BP; Beilin LJ; Schofield T; Benedict CR; Barker NP; Cooper R
    Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of atenolol in hypertensive patients.
    Ibrahim MM; Mossallam R
    Circulation; 1981 Aug; 64(2):368-74. PubMed ID: 7249304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
    Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
    Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
    Sasaki Y; Arakawa K
    Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of atenolol and metoprolol in the treatment of hypertension.
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Br J Clin Pharmacol; 1981 Dec; 12(6):887-91. PubMed ID: 7340890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
    Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atenolol and metoprolol once daily in hypertension.
    Scott AK; Rigby JW; Webster J; Hawksworth GM; Petrie JC; Lovell HG
    Br Med J (Clin Res Ed); 1982 May; 284(6328):1514-6. PubMed ID: 6805588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.
    Marshall AJ; Barritt DW; Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():168-72. PubMed ID: 337271
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the duration of antihypertensive action of atenolol and metoprolol over a 24-hour period.
    Crowe PF; Ferguson RJ
    Curr Med Res Opin; 1985; 9(7):431-5. PubMed ID: 4028805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
    Nilsson OR; Karlberg BE; Henningsen NC; Thulin T
    Acta Med Scand Suppl; 1982; 665():117-9. PubMed ID: 6760679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG; Hampton JR
    Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.